Pacer Advisors, Inc. Moderna, Inc. Transaction History

Pacer Advisors, Inc.

$38.6 Billion
Q1 2024

A detailed history of Pacer Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 41,368 shares of MRNA stock, worth $4.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

41,368

Previous 45,392 8.86%

Holding current value

$4.8 Million

Previous $4.51 Million 2.35%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $343,528 - $464,530	-4,024 Reduced 8.86%	41,368 $4.41 Million
Q4 2023 Jan 16, 2024	SELL	$69.51 - $104.43 $552,674 - $830,322	-7,951 Reduced 14.91%	45,392 $4.51 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $2.65 Million - $3.49 Million	-27,538 Reduced 34.05%	53,343 $5.51 Million
Q2 2023 Jul 12, 2023	SELL	$118.5 - $160.53 $2.19 Million - $2.96 Million	-18,448 Reduced 18.57%	80,881 $9.83 Million
Q1 2023 May 02, 2023	SELL	$135.66 - $197.02 $153 Million - $222 Million	-1,126,738 Reduced 91.9%	99,329 $15.3 Million

Q4 2022 Feb 06, 2023	BUY	$118.38 - $210.04 $6.75 Million - $12 Million	57,020 Added 4.88%	1,226,067 $220 Million
Q3 2022 Oct 18, 2022	BUY	$118.07 - $194.18 $17.7 Million - $29.1 Million	149,879 Added 14.71%	1,169,047 $138 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $51.3 Million - $77.4 Million	438,198 Added 75.43%	1,019,168 $146 Million
Q1 2022 Apr 05, 2022	BUY	$126.46 - $235.05 $58.9 Million - $109 Million	465,401 Added 402.7%	580,970 $100 Million
Q4 2021 Feb 03, 2022	BUY	$225.82 - $368.51 $18.9 Million - $30.8 Million	83,543 Added 260.86%	115,569 $29.4 Million
Q3 2021 Oct 15, 2021	SELL	$221.9 - $484.47 $9.66 Million - $21.1 Million	-43,512 Reduced 57.6%	32,026 $12.3 Million
Q2 2021 Jul 21, 2021	BUY	$129.91 - $234.98 $7.94 Million - $14.4 Million	61,087 Added 422.72%	75,538 $17.8 Million
Q1 2021 Apr 05, 2021	SELL	$109.18 - $185.98 $116,167 - $197,882	-1,064 Reduced 6.86%	14,451 $1.89 Million
Q4 2020 Jan 20, 2021	SELL	$65.74 - $169.86 $919,373 - $2.38 Million	-13,985 Reduced 47.41%	15,515 $1.62 Million
Q3 2020 Oct 19, 2020	BUY	$54.34 - $94.85 $1.59 Million - $2.77 Million	29,190 Added 9416.13%	29,500 $2.09 Million
Q2 2020 Jul 29, 2020	BUY	$29.67 - $80.0 $9,197 - $24,800	310 New	310 $20,000

Others Institutions Holding MRNA

# of Institutions

1,038

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Moderna, Inc. Transaction History